As presented in Figure 4E–4G, ovarian cancer patients with higher expression of GJB2, S100A2 and SPOCK2 showed better OS, which was identical with the analytic results obtained from TCGA cohort. The gene discussed is SPOCK2; the disease is ovarian cancer.